NCT00545090View on ClinicalTrials.gov

ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

PHASE4CompletedINTERVENTIONAL
Enrollment

561

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Post Menopausal Osteoporosis
Interventions
DRUG

ibandronate [Bonviva/Boniva]

150mg po monthly for 6 months

Trial Locations (17)

100

Taipei

333

Taoyuan District

404

Taichung

407

Taichung

500

Changhua

704

Tainan City

852

Hong Kong

1015

Manila

1100

Quezon City

10330

Bangkok

10400

Bangkok

10430

Jakarta

40002

Khon Kaen

50200

Chiang Mai

60286

Surabaya

90174

Makassar

00112

Taipei

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00545090 - ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. | Biotech Hunter | Biotech Hunter